Ganaxolone for management of seizures associated with CDKL5 deficiency disorder

Trends Pharmacol Sci. 2023 Feb;44(2):128-129. doi: 10.1016/j.tips.2022.11.007. Epub 2022 Dec 12.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Epileptic Syndromes* / complications
  • Epileptic Syndromes* / drug therapy
  • Humans
  • Protein Serine-Threonine Kinases
  • Seizures / drug therapy
  • Spasms, Infantile* / complications
  • Spasms, Infantile* / drug therapy

Substances

  • ganaxolone
  • CDKL5 protein, human
  • Protein Serine-Threonine Kinases

Supplementary concepts

  • CDKL5 deficiency disorder

Associated data

  • ClinicalTrials.gov/NCT03572933
  • ClinicalTrials.gov/NCT05249556